Parkwood LLC Novo Nordisk A S Transaction History

Parkwood LLC

$1.42 Billion
Q3 2024

A detailed history of Parkwood LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Parkwood LLC holds 263,980 shares of NVO stock, worth $28.5 Million. This represents 2.21% of its overall portfolio holdings.

Number of Shares

263,980

Previous 236,039 11.84%

Holding current value

$28.5 Million

Previous $33.7 Million 6.71%

% of portfolio

2.21%

Previous 4.19%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $3.33 Million - $4.06 Million	27,941 Added 11.84%	263,980 $31.4 Million
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $7.52 Million - $9 Million	61,245 Added 35.04%	236,039 $33.7 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $2.86 Million - $3.8 Million	27,966 Added 19.05%	174,794 $22.4 Million
Q4 2023 Feb 14, 2024	SELL	$87.78 - $105.45 $1.95 Million - $2.34 Million	-22,186 Reduced 13.13%	146,828 $15.2 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $8.5 Million - $18.6 Million	93,445 Added 123.66%	169,014 $15.4 Million
Q2 2023 Aug 14, 2023	SELL	$155.98 - $172.65 $3.71 Million - $4.11 Million	-23,817 Reduced 23.96%	75,569 $12.2 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $8.13 Million - $9.78 Million	61,430 Added 161.85%	99,386 $15.8 Million
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $3.89 Million - $5.14 Million	37,956 New	37,956 $5.14 Million
Q2 2022 Aug 15, 2022	SELL	$103.24 - $121.81 $5.93 Million - $7 Million	-57,476 Reduced 61.89%	35,389 $35,000
Q1 2022 May 13, 2022	BUY	$93.1 - $112.54 $2.21 Million - $2.68 Million	23,791 Added 34.44%	92,865 $10.3 Million
Q4 2021 Feb 11, 2022	SELL	$95.88 - $117.08 $119,370 - $145,764	-1,245 Reduced 1.77%	69,074 $7.74 Million
Q3 2021 Nov 12, 2021	SELL	$84.42 - $106.62 $1.65 Million - $2.09 Million	-19,585 Reduced 21.78%	70,319 $6.75 Million
Q2 2021 Aug 13, 2021	SELL	$67.66 - $84.76 $64,412 - $80,691	-952 Reduced 1.05%	89,904 $7.53 Million
Q1 2021 May 14, 2021	BUY	$67.06 - $75.82 $591,938 - $669,263	8,827 Added 10.76%	90,856 $6.13 Million
Q4 2020 Feb 12, 2021	SELL	$63.89 - $73.8 $734,607 - $848,552	-11,498 Reduced 12.29%	82,029 $5.73 Million
Q3 2020 Nov 12, 2020	BUY	$63.69 - $70.22 $1.42 Million - $1.56 Million	22,270 Added 31.25%	93,527 $6.49 Million
Q2 2020 Aug 11, 2020	BUY	$58.54 - $67.94 $4.17 Million - $4.84 Million	71,257 New	71,257 $4.67 Million

Others Institutions Holding NVO

# of Institutions

1,956

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $244B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkwood LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkwood LLC with notifications on news.

Account